Artificial Inteligence-Based Decision for the Prediction of Cardioembolism in Patients with Chagas Disease and

Vinícius Viana Abreu Montanaro1, Thiago Falcão Hora2, Agostinho Alencar Guerra2

  • 1SARAH Network of Rehabilitation Hospitals, Brasília, Brazil; Programa de Pós Graduação em Medicina (Neurologia) da Universidade Federal Fluminense - UFF, Niterói, RJ, Brazil.

Insights

Chagas disease (CD) and ischemic stroke (IS) share a link, with younger patients exhibiting cardioembolic events and higher risk factors. A new predictive model aids in identifying patients for optimized secondary prophylaxis.

Area of Science:

  • Cardiology
  • Neurology
  • Infectious Diseases

Background:

  • The association between Chagas disease (CD) and ischemic stroke (IS) is not fully understood.
  • Limited evidence exists for secondary prophylaxis and etiological determination in CD-IS patients, with few identified cardioembolic cases.

Purpose of the Study:

  • To describe a multicenter cohort of patients with both CD and IS.
  • To develop a predictive model for cardioembolic embolism in patients with CD and IS.

Main Methods:

  • Retrospective analysis of electronic and regular medical records from Brazilian hospitals.
  • Descriptive analyses comparing cardioembolic and non-cardioembolic CD-IS patients.
  • Development and validation of a predictive model for cardioembolism using 70% derivation and 30% validation samples.

Main Results:

  • 499 patients were analyzed; cardioembolic patients were younger with higher rates of alcoholism, smoking, and mortality.
  • The predictive model correlated with echocardiographic/electrocardiographic abnormalities and vascular risk factors.

Conclusions:

  • Vascular risk factors are more prevalent and patients are younger in the cardioembolic CD-IS group.
  • The developed predictive model can identify patients at higher risk for recurrence, enabling optimized secondary prophylaxis strategies.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
49
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.0K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
75
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
440